AG˹ٷ

STOCK TITAN

[Form 4] SELECT MEDICAL HOLDINGS CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 30 Jun 2025, four Canadian investment firms jointly filed a Schedule 13G disclosing a new >5 % passive stake in Gildan Activewear Inc. (NYSE: GIL).

  • Total beneficial ownership: 7,678,872 common shares, representing 5.10 % of shares outstanding.
  • Largest holder: Jarislowsky, Fraser Ltd. with 7,412,206 shares (4.92 %).
  • Other filers: 1832 Asset Management L.P. (61,336); MD Financial Management Inc. (105,450); Scotia McLeod / Scotia Capital (99,880).
  • Sole voting & dispositive power: 7,678,272 shares; shared power: 600 shares.
  • Filed under Rule 13d-1(b) as institutional investors (FI/IA); certification states the stake is held in the ordinary course with no intent to influence control.

The disclosure signals incremental institutional interest but does not indicate activist activity or strategic intent. Investors may view the ownership as a modest vote of confidence from well-known Canadian asset managers.

Il 30 giugno 2025, quattro società di investimento canadesi hanno presentato congiuntamente un Schedule 13G rivelando una nuova partecipazione passiva superiore al 5% in Gildan Activewear Inc. (NYSE: GIL).

  • Partecipazione totale: 7.678.872 azioni ordinarie, pari al 5,10% del capitale sociale.
  • Maggiore azionista: Jarislowsky, Fraser Ltd. con 7.412.206 azioni (4,92%).
  • Altri firmatari: 1832 Asset Management L.P. (61.336); MD Financial Management Inc. (105.450); Scotia McLeod / Scotia Capital (99.880).
  • Potere esclusivo di voto e disposizione: 7.678.272 azioni; potere condiviso: 600 azioni.
  • Presentato ai sensi della Regola 13d-1(b) come investitori istituzionali (FI/IA); la certificazione dichiara che la partecipazione è detenuta nell'ordinaria gestione senza intento di influenzare il controllo.

La comunicazione segnala un interesse istituzionale crescente ma non indica attività attiviste o intenti strategici. Gli investitori possono interpretare questa partecipazione come un modesto segnale di fiducia da parte di noti gestori patrimoniali canadesi.

El 30 de junio de 2025, cuatro firmas de inversión canadienses presentaron conjuntamente un Schedule 13G revelando una nueva participación pasiva superior al 5% en Gildan Activewear Inc. (NYSE: GIL).

  • Propiedad beneficiosa total: 7.678.872 acciones comunes, que representan el 5,10% de las acciones en circulación.
  • Mayor accionista: Jarislowsky, Fraser Ltd. con 7.412.206 acciones (4,92%).
  • Otros declarantes: 1832 Asset Management L.P. (61.336); MD Financial Management Inc. (105.450); Scotia McLeod / Scotia Capital (99.880).
  • Poder exclusivo de voto y disposición: 7.678.272 acciones; poder compartido: 600 acciones.
  • Presentado bajo la Regla 13d-1(b) como inversores institucionales (FI/IA); la certificación indica que la participación se mantiene en el curso ordinario sin intención de influir en el control.

La divulgación señala un interés institucional incremental pero no indica actividad activista o intención estratégica. Los inversores pueden ver esta propiedad como un modesto voto de confianza de reconocidos gestores de activos canadienses.

2025� 6� 30�, � 개의 캐나� 투자 회사가 공동으로 Schedule 13G� 제출하여 Gildan Activewear Inc. (NYSE: GIL)� 대� 5% 이상� 새로� 수동 지분을 공개했습니다.

  • � 실질 소유 지�: 7,678,872 보통주로, 발행 주식� 5.10%� 해당합니�.
  • 최대 보유�: Jarislowsky, Fraser Ltd.가 7,412,206� (4.92%)� 보유하고 있습니다.
  • 기타 제출�: 1832 Asset Management L.P. (61,336); MD Financial Management Inc. (105,450); Scotia McLeod / Scotia Capital (99,880).
  • 단독 의결 � 처분 권한: 7,678,272�; 공동 권한: 600�.
  • Rule 13d-1(b)� 따라 기관 투자�(FI/IA)로서 제출되었으며, 보유 지분은 통상적인 과정에서 보유 중이� 경영권에 영향� 미칠 의도가 없음� 인증합니�.

이번 공시� 기관 투자자의 점진적인 관� 증가� 나타내지�, 행동주의 활동이나 전략� 의도� 의미하지� 않습니다. 투자자들은 � 지분을 � 알려� 캐나� 자산 운용사들� 소규� 신뢰 표시� � � 있습니다.

Le 30 juin 2025, quatre sociétés d'investissement canadiennes ont conjointement déposé un Schedule 13G révélant une nouvelle participation passive supérieure à 5 % dans Gildan Activewear Inc. (NYSE: GIL).

  • Propriété bénéficiaire totale : 7 678 872 actions ordinaires, représentant 5,10 % des actions en circulation.
  • Principal détenteur : Jarislowsky, Fraser Ltd. avec 7 412 206 actions (4,92 %).
  • Autres déclarants : 1832 Asset Management L.P. (61 336) ; MD Financial Management Inc. (105 450) ; Scotia McLeod / Scotia Capital (99 880).
  • Pouvoir exclusif de vote et de disposition : 7 678 272 actions ; pouvoir partagé : 600 actions.
  • Déposé conformément à la règle 13d-1(b) en tant qu'investisseurs institutionnels (FI/IA) ; la certification indique que la participation est détenue dans le cours normal des affaires sans intention d'influencer le contrôle.

Cette divulgation signale un intérêt institutionnel croissant mais n'indique pas d'activité activiste ni d'intention stratégique. Les investisseurs peuvent considérer cette participation comme un modeste signe de confiance de la part de gestionnaires d'actifs canadiens bien connus.

Am 30. Juni 2025 reichten vier kanadische Investmentfirmen gemeinsam ein Schedule 13G ein, das eine neue passive Beteiligung von über 5 % an Gildan Activewear Inc. (NYSE: GIL) offenlegt.

  • Gesamtes wirtschaftliches Eigentum: 7.678.872 Stammaktien, was 5,10 % der ausstehenden Aktien entspricht.
  • Größter Anteilseigner: Jarislowsky, Fraser Ltd. mit 7.412.206 Aktien (4,92 %).
  • Weitere Einreicher: 1832 Asset Management L.P. (61.336); MD Financial Management Inc. (105.450); Scotia McLeod / Scotia Capital (99.880).
  • Alleiniges Stimm- und Verfügungsrecht: 7.678.272 Aktien; geteilte Rechte: 600 Aktien.
  • Unter Regel 13d-1(b) als institutionelle Investoren (FI/IA) eingereicht; die Zertifizierung besagt, dass die Beteiligung im normalen Geschäftsverlauf gehalten wird, ohne die Absicht, die Kontrolle zu beeinflussen.

Die Meldung signalisiert ein zunehmendes institutionelles Interesse, weist jedoch nicht auf aktivistische Aktivitäten oder strategische Absichten hin. Anleger könnten die Beteiligung als ein moderates Vertrauensvotum von bekannten kanadischen Vermögensverwaltern sehen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Passive 5.1 % stake by Canadian funds adds institutional support; market impact likely muted.

The combined group barely crosses the 5 % threshold, triggering mandatory disclosure. Jarislowsky, Fraser accounts for virtually the entire position, consistent with its long-only, value-oriented strategy. Because the filing is on Schedule 13G—not 13D—there is no activist agenda, limiting governance implications. That said, additional transparency on a 5 % holder can improve liquidity perception and may be viewed positively by some investors. Valuation upside is limited unless the stake grows or converts to an activist 13D. Overall impact is neutral, with a slight positive tilt due to institutional endorsement.

TL;DR: Disclosure fulfills compliance; no control intent, governance ramifications minimal.

Because voting and dispositive power remain solely with the reporting advisers and shared voting is only 600 shares, there is negligible risk of coordinated control. The certification explicitly rules out influence on management or board composition. From a governance standpoint, the filing merely updates the ownership register and ensures transparency to minority shareholders. Unless the group converts to a 13D filer, strategic impact is insubstantial.

Il 30 giugno 2025, quattro società di investimento canadesi hanno presentato congiuntamente un Schedule 13G rivelando una nuova partecipazione passiva superiore al 5% in Gildan Activewear Inc. (NYSE: GIL).

  • Partecipazione totale: 7.678.872 azioni ordinarie, pari al 5,10% del capitale sociale.
  • Maggiore azionista: Jarislowsky, Fraser Ltd. con 7.412.206 azioni (4,92%).
  • Altri firmatari: 1832 Asset Management L.P. (61.336); MD Financial Management Inc. (105.450); Scotia McLeod / Scotia Capital (99.880).
  • Potere esclusivo di voto e disposizione: 7.678.272 azioni; potere condiviso: 600 azioni.
  • Presentato ai sensi della Regola 13d-1(b) come investitori istituzionali (FI/IA); la certificazione dichiara che la partecipazione è detenuta nell'ordinaria gestione senza intento di influenzare il controllo.

La comunicazione segnala un interesse istituzionale crescente ma non indica attività attiviste o intenti strategici. Gli investitori possono interpretare questa partecipazione come un modesto segnale di fiducia da parte di noti gestori patrimoniali canadesi.

El 30 de junio de 2025, cuatro firmas de inversión canadienses presentaron conjuntamente un Schedule 13G revelando una nueva participación pasiva superior al 5% en Gildan Activewear Inc. (NYSE: GIL).

  • Propiedad beneficiosa total: 7.678.872 acciones comunes, que representan el 5,10% de las acciones en circulación.
  • Mayor accionista: Jarislowsky, Fraser Ltd. con 7.412.206 acciones (4,92%).
  • Otros declarantes: 1832 Asset Management L.P. (61.336); MD Financial Management Inc. (105.450); Scotia McLeod / Scotia Capital (99.880).
  • Poder exclusivo de voto y disposición: 7.678.272 acciones; poder compartido: 600 acciones.
  • Presentado bajo la Regla 13d-1(b) como inversores institucionales (FI/IA); la certificación indica que la participación se mantiene en el curso ordinario sin intención de influir en el control.

La divulgación señala un interés institucional incremental pero no indica actividad activista o intención estratégica. Los inversores pueden ver esta propiedad como un modesto voto de confianza de reconocidos gestores de activos canadienses.

2025� 6� 30�, � 개의 캐나� 투자 회사가 공동으로 Schedule 13G� 제출하여 Gildan Activewear Inc. (NYSE: GIL)� 대� 5% 이상� 새로� 수동 지분을 공개했습니다.

  • � 실질 소유 지�: 7,678,872 보통주로, 발행 주식� 5.10%� 해당합니�.
  • 최대 보유�: Jarislowsky, Fraser Ltd.가 7,412,206� (4.92%)� 보유하고 있습니다.
  • 기타 제출�: 1832 Asset Management L.P. (61,336); MD Financial Management Inc. (105,450); Scotia McLeod / Scotia Capital (99,880).
  • 단독 의결 � 처분 권한: 7,678,272�; 공동 권한: 600�.
  • Rule 13d-1(b)� 따라 기관 투자�(FI/IA)로서 제출되었으며, 보유 지분은 통상적인 과정에서 보유 중이� 경영권에 영향� 미칠 의도가 없음� 인증합니�.

이번 공시� 기관 투자자의 점진적인 관� 증가� 나타내지�, 행동주의 활동이나 전략� 의도� 의미하지� 않습니다. 투자자들은 � 지분을 � 알려� 캐나� 자산 운용사들� 소규� 신뢰 표시� � � 있습니다.

Le 30 juin 2025, quatre sociétés d'investissement canadiennes ont conjointement déposé un Schedule 13G révélant une nouvelle participation passive supérieure à 5 % dans Gildan Activewear Inc. (NYSE: GIL).

  • Propriété bénéficiaire totale : 7 678 872 actions ordinaires, représentant 5,10 % des actions en circulation.
  • Principal détenteur : Jarislowsky, Fraser Ltd. avec 7 412 206 actions (4,92 %).
  • Autres déclarants : 1832 Asset Management L.P. (61 336) ; MD Financial Management Inc. (105 450) ; Scotia McLeod / Scotia Capital (99 880).
  • Pouvoir exclusif de vote et de disposition : 7 678 272 actions ; pouvoir partagé : 600 actions.
  • Déposé conformément à la règle 13d-1(b) en tant qu'investisseurs institutionnels (FI/IA) ; la certification indique que la participation est détenue dans le cours normal des affaires sans intention d'influencer le contrôle.

Cette divulgation signale un intérêt institutionnel croissant mais n'indique pas d'activité activiste ni d'intention stratégique. Les investisseurs peuvent considérer cette participation comme un modeste signe de confiance de la part de gestionnaires d'actifs canadiens bien connus.

Am 30. Juni 2025 reichten vier kanadische Investmentfirmen gemeinsam ein Schedule 13G ein, das eine neue passive Beteiligung von über 5 % an Gildan Activewear Inc. (NYSE: GIL) offenlegt.

  • Gesamtes wirtschaftliches Eigentum: 7.678.872 Stammaktien, was 5,10 % der ausstehenden Aktien entspricht.
  • Größter Anteilseigner: Jarislowsky, Fraser Ltd. mit 7.412.206 Aktien (4,92 %).
  • Weitere Einreicher: 1832 Asset Management L.P. (61.336); MD Financial Management Inc. (105.450); Scotia McLeod / Scotia Capital (99.880).
  • Alleiniges Stimm- und Verfügungsrecht: 7.678.272 Aktien; geteilte Rechte: 600 Aktien.
  • Unter Regel 13d-1(b) als institutionelle Investoren (FI/IA) eingereicht; die Zertifizierung besagt, dass die Beteiligung im normalen Geschäftsverlauf gehalten wird, ohne die Absicht, die Kontrolle zu beeinflussen.

Die Meldung signalisiert ein zunehmendes institutionelles Interesse, weist jedoch nicht auf aktivistische Aktivitäten oder strategische Absichten hin. Anleger könnten die Beteiligung als ein moderates Vertrauensvotum von bekannten kanadischen Vermögensverwaltern sehen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Frist William H.

(Last) (First) (Middle)
C/O SELECT MEDICAL HOLDINGS CORPORATION
4714 GETTYSBURG ROAD

(Street)
MECHANICSBURG PA 17055

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SELECT MEDICAL HOLDINGS CORP [ SEM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/29/2025 A(1) 1,263 A $14.25 288,762 D
Common Stock 07/29/2025 A(2) 14,035 A $0 302,797 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This grant of restricted stock was issued to the reporting person pursuant to the Select Medical Holdings Corporation 2020 Equity Incentive Plan in lieu of a quarterly retainer of $18,000.
2. Grant of restricted stock which, subject to certain exceptions, will vest in full on July 29, 2026, the first anniversary of the grant date.
/s/ Michael E. Tarvin, Attorney-in-Fact 07/31/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Gildan Activewear (GIL) shares are reported in the Schedule 13G?

The filing reports 7,678,872 common shares, equal to 5.10 % of outstanding shares.

Who is the largest holder in the 13G filing for GIL?

Jarislowsky, Fraser Limited holds 7,412,206 shares (4.92 % of the company).

Is the reported stake activist in nature?

No. The group filed on Schedule 13G, certifying passive investment with no intent to influence control.

What triggered the need to file this Schedule 13G?

Crossing the 5 % ownership threshold on 30 Jun 2025 required disclosure under SEC Rule 13d-1(b).

Which Canadian investment firms are included in the joint filing?

1832 Asset Management L.P., MD Financial Management Inc., Scotia McLeod (Scotia Capital), and Jarislowsky, Fraser Limited.
Select Medical

NYSE:SEM

SEM Rankings

SEM Latest News

SEM Latest SEC Filings

SEM Stock Data

1.86B
110.06M
14.6%
83.81%
3.47%
Medical Care Facilities
Services-hospitals
United States
MECHANICSBURG